What It Is HGH Fragment 176-191 is a synthetic peptide representing the C-terminal amino acid sequence 176–191 of the human growth hormone molecule. This fragment has been shown in preclinical studies to retain the lipolytic (fat-mobilising) properties of full-length HGH without the associated anabolic or diabetogenic effects linked to full GH receptor activation. The fragment is proposed to act on beta-3 adrenergic receptors in adipose tissue, stimulating the breakdown of stored triglycerides and inhibiting new lipid formation. It does not stimulate IGF-1 production or exhibit growth-promoting activity.
How It Is Used HGH Fragment 176-191 is reconstituted with bacteriostatic water and administered via subcutaneous injection in research contexts. It is studied in adipose biology models, metabolic research, and investigations into targeted lipolysis and body composition regulation.
All Genovare products are manufactured in-house under strict quality control protocols, utilizing the highest grade synthesis methods, third-party purity verification, and rigorous sterility standards to ensure consistent, research-grade output in every batch.
This site is for informational purposes only and does not constitute medical advice. These products are not for sale.
Choosing a selection results in a full page refresh.
